“…23 The feasibility of using pp65 expressed in adenovirus, 24,25 retrovirus, 26 or poxvirus 27 to induce robust CTL response has been demonstrated. In a recent phase 1 trial, CMV-seronegative volunteers were vaccinated with an attenuated strain of canarypox virus (ALVAC) expressing CMV pp65, and they developed robust cellular immunity, equivalent to levels measured in CMV-positive individuals.…”